2009
DOI: 10.5858/133.8.1242
|View full text |Cite
|
Sign up to set email alerts
|

Bilateral Massive Retinal Gliosis Associated With Retinopathy of Prematurity

Abstract: Massive retinal gliosis (MRG) is a rare, benign intraocular condition that may develop in association with long-standing eye conditions including chronic inflammation, vascular disorders, glaucoma, trauma, or congenital abnormalities. It is thought to represent a nonneoplastic reactive tissue response to retinal injury. Here, we describe an unusual case of bilateral MRG in association with retinopathy of prematurity. To our knowledge, this may be the first report of such an occurrence. The differential diagnos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 12 publications
0
7
0
Order By: Relevance
“…MRG represents a benign, intraocular, reactive proliferation of glial tissue occurring in response to variable insults. The reported inciting factors include chronic inflammation, trauma, vascular abnormalities, glaucoma, and retinal diseases such as long-standing retinal detachment and retinopathy of prematurity [4,5]. In our case, the presentation was late in onset and no triggering events were found.…”
Section: Discussionmentioning
confidence: 58%
“…MRG represents a benign, intraocular, reactive proliferation of glial tissue occurring in response to variable insults. The reported inciting factors include chronic inflammation, trauma, vascular abnormalities, glaucoma, and retinal diseases such as long-standing retinal detachment and retinopathy of prematurity [4,5]. In our case, the presentation was late in onset and no triggering events were found.…”
Section: Discussionmentioning
confidence: 58%
“…In humans, massive retinal gliosis is a rare, benign, intraocular condition that develops in association with other ocular diseases and is mainly constituted by Müller cell activation [ 150 ]. There are only a couple, not very recent, case reports describing the association between massive retinal gliosis and ROP [ 151 , 152 ]. One of them reported the presence of bilateral massive gliosis in a 39-year-old man born prematurely that developed severe ROP with retinal detachment [ 151 ], suggesting that severe ROP may have deleterious effects during the patient life.…”
Section: The Impact Of Rop In the Central Nervous Systemmentioning
confidence: 99%
“…There are only a couple, not very recent, case reports describing the association between massive retinal gliosis and ROP [ 151 , 152 ]. One of them reported the presence of bilateral massive gliosis in a 39-year-old man born prematurely that developed severe ROP with retinal detachment [ 151 ], suggesting that severe ROP may have deleterious effects during the patient life. Although no clinical evidence indicates that gliosis may participate in ROP pathogenesis, results in preclinical models suggest this possibility.…”
Section: The Impact Of Rop In the Central Nervous Systemmentioning
confidence: 99%
“…Massive retinal gliosis (MRG) is a rare, benign intraocular condition that may develop in association with longstanding eye conditions, including chronic inflammation, vascular disorders, glaucoma, trauma, prematurity retinopathy, surgery, and congenital abnormalities (microphthalmos and cyst). [1][2][3][4][5] It may represent a non-neoplastic reactive tissue response to retinal injury. 6 We describe an unusual case of MRG-like, which occurred 20 years after evisceration.…”
mentioning
confidence: 99%
“…The differential diagnosis of such an intraocular lesion includes uveal melanoma, astrocytic hamartoma, retinal hemangioblastomas, tumours of the retinal pigment epithelium, metastasis, schwannoma of ciliary nerves, and vasoproliferative tumours of the retina. [1][2][3][4][5]8,9 This case is differentiated from these alternative diagnoses based on patient history and previous clinical examinations data and on the histopathological features and immunohistochemistry of the lesions.…”
mentioning
confidence: 99%